EdgarLookup

Travere Therapeutics, Inc. — SC 13G/A Filings

66 SC 13G/A filings on record

This page lists all SC 13G/A filings submitted to the SEC by Travere Therapeutics, Inc. (TVTX), sorted by most recent first. Each row links to the full filing on EdgarLookup. Travere Therapeutics, Inc. has filed 66 SC 13G/A documents with the SEC since 2014. To view all SEC filings by Travere Therapeutics, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-12G 10-12G/A 10-K 10-K/A 10-Q 10-Q/A 144 3 3/A 305B2 4 4/A 424B1 424B3 424B5 5 8-A12B 8-K 8-K/A ARS CERTNAS CORRESP CT ORDER D DEF 14A DEFA14A DRS DRS/A EFFECT FWP NT 10-K NT 10-Q PRE 14A RW S-1 S-1/A S-3 S-3/A S-3ASR S-3MEF S-8 SC 13D SC 13D/A SC 13G SC 13G/A SC 14F1 SC 14F1/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
SC 13G/A 13G AMENDED ANNUAL FILING (RTRX) 0000053417-17-000100 Feb 3, 2017
SC 13G/A 0000353480-17-001644 Jan 25, 2017
SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001193125-16-645452 Jul 11, 2016
SC 13G/A RETROPHIN, INC. 0000902664-16-005791 Feb 16, 2016
SC 13G/A 0000919574-16-010379 Feb 12, 2016
SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-16-002997 Feb 11, 2016
SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0001193125-16-457827 Feb 11, 2016
SC 13G/A 13G AMENDED ANNUAL FILING - (RTRX) 0000053417-16-000299 Feb 5, 2016
SC 13G/A 13G AMENDED MONTHLY FILING - RTRX 0000053417-15-000194 Oct 9, 2015
SC 13G/A SCHEDULE 13G AMENDMENT NO. 2 0001193125-15-051210 Feb 17, 2015
SC 13G/A 0000919574-15-001878 Feb 17, 2015
SC 13G/A 13G AMENDED ANNUAL FILING - RTRX 0000053417-15-000156 Feb 11, 2015
SC 13G/A 13G AMENDED MONTHLY FILING - RTRX 0000053417-14-000190 May 7, 2014
SC 13G/A AMENDMENT NO. 1 0000899140-14-000358 Apr 2, 2014
SC 13G/A SCHEDULE 13G AMENDMENT NO. 1 0001193125-14-054110 Feb 14, 2014
SC 13G/A SABBY 13G-A RTRX 01.13.14 0001535610-14-000020 Jan 13, 2014